652. Expression and Regulation of the Coxsackie- and Adenovirus Receptor (CAR) in Premalignant Lesions and Advanced Neoplasms

!"!"       

 6:    (# 3  5   

  F"      

  #)M89 β"   1

   

#)M&99   (#"      (##C    )(";      

   ' &"!!" 5 ' &"!#>!" 5   ' &" !@>!" 5#)M89 )*)7       

    8 .       5

3   

  #>#.  

         F"   ' &" 5-O9998/' &"!@>!" 5                (#       #>#."

   - O9998/ ' &"!#>!" 5               @' =B    ' &"!!" 5   -O998/ β"     

           3  ' #>#."

     

        ' &" 5-O9998/.    0!@> 

    @' =B-O998/' &"!#>!" 5       ' &"!!" 5  ' &"!@>!" 5         3   (#          #>#."

    - O9998/ ' &" !@>!" 5  

  3 59"        ' &" 5 *       

  

   β"      

  )(";    ' &"!!" ' &"!#>!"   ' &"!@>!" 5 (*)+()7     0!@>           

 (##C        3                      3             (# 2   

     3                  



  

                

       Ad5-lacZ

RAd36

Ad5-PPlacZ 24.0±1.0

Ad5-PMEP- Ad5-PREP- p lacZ lacZ (ANOVA) 12.2±0.5 36.6±2.0 <0.0001

Proportion of SMC 1.0±0.1 13.4±1.0 expressing lacZ (%) β-gal. activity in 0.01±0.005 0.178±0.04 0.427±0.02 0.419±0.06 0.865±0.12 <0.0001 SMC lysates (IU/mg protein/ml) β-gal. activity in — n/a — — n/a -— 0.038±0.004 0.051±0.002 0.056±0.006 0.10 COS-7 lysates (IU/mg protein/ml)

652. Expression and Regulation of the Coxsackie- and Adenovirus Receptor (CAR) in Premalignant Lesions and Advanced Neoplasms M. Anders,1 C. Christian,1 R. Warren,1 A. Balmain,1 M. J. Bissell,2 F. McCormick,1 W. M. Korn.1 1 Comprehensive Cancer Center, University of California, San Francisco, CA, United States; 2Lawrence Berkeley National Laboratories, Berkeley, CA, United States.     

 3 "  '   @    -'@/                         '     

         3

                -     /   

      3   '@                       

 0  3

'@ 3       $(                            

 1      '@ 3         

  '@      3                    

 

   '@ 3  

            3   '@ 

      

"           

                    0                   '@

3   

                   

                 @"8%#'!A         '@ 3         

  "   3   '@    

      "      0                               " 

    ?    E        '@

3    

   2

         G

S214

                    

                 

     

653. Combining T ransductional-T argeting with Transductional-T ransductional-Targeting Translational-T argeting for Prostate Cancer Adenoviralranslational-Targeting Mediated Oncolytic Effect Thomas A. Gardner,1 Sudhanshu P. Raikwar,2 Victor Krasnykh,1 Chinghai Kao.1 1 Dept of Urology, Microbiology and Immunology, Walther Oncology Center, Indiana University Medical Center, Indianapolis, IN, United States; 2Division of Human Gene Therapy, University of Alabama at Birmingham, Birmingham, AL, United States.        

              3                  

                                       3

             )     

 @$           "       

      '       @$ 

 

  

    4@$   

        

 @' ?")>8'   

 

        

@' )>8'! 

    -D*! 6", !"=/           -@",5/     

     &389&  %   3     ,6               

  98   8     %    6    899        &99    

 '  6          

   ,  

  

           

   ,   &          

   &          

    

     1    ,5=   )           

  D*!   6",         

   8 %     @' )>8'       

 

  6",    

  D*!   *  

      

    !"=   @",5     2  &  ;9H  6",    

   98   

    

      899H     

   8 %  3 

       @' ?")>8' @$   

   6",    

       

 @' ")>8'  

  59H !>   899H !>  98%    8 %       

              D*!       

@' ?")>8'      89H      3 

    

   98 %     B9H    D*!   3 

     8 %  ?   1            !>  

      @$   

                  

                            

        

                   $       A       $       

     G

    3  

654. Reduction of Adenoviral Natural T ropism to Liver Tropism by Both Ablation of Fiber-CAR Interaction and Use of Replaceable Short Fiber Takafumi Nakamura,1,2 Kenzo Sato,2 Hirofumi Hamada.1 1 Department of Molecular Medicine, Sapporo Medical University, Sapporo, Japan; 2Department of Molecular Biology, Tottori University, Yonago, Japan.               -' /  

       



     

                   3          -'@/       '       

       

                 

         69 -' 69/           I            G  '@           '@ 0    

      & -' &/"

        7 ?%69(D 

   ' &          ' 69 ?%69( 

  ' &       ' 69      ?%&69( 

    Molecular Therapy Vol. 5, No. 5, May 2002, Part 2 of 2 Parts Copyright © The American Society of Gene Therapy